Related content

Guanidinobenzoic Acid Inhibitors of Influenza Virus Neuraminidase

By Sudbeck E.A.   Jedrzejas M.J.   Singh S.   Brouillette W.J.   Air G.M.   Laver W.G.   Babu Y.S.   Bantia S.   Chand P.   Chu N.   Montgomery J.A.   Walsh D.A.   Luo M.  

Journal of Molecular Biology, Vol. 267, Iss. 3, 1997-04 ,pp. : 584-594

Academic Press

Access to resources Recommend Favorite

De novo design of quinazoline derivatives as CDK2 inhibitors: 3D-QSAR, molecular fragment replacement and Volsurf predictions

By Wang Jian   Chen Ya-Dong   Liu Hai-Chun   Lin Guo-Wu   Yang Tao-Tao   Yuan Hao-Liang   Ran Ting   Lu Shuai   Zhang Wei-Wei   Leng Ying   Lu Tao  

Molecular Simulation, Vol. 37, Iss. 10, 2011-09 ,pp. : 824-836

Taylor & Francis Ltd

Access to resources Recommend Favorite

Pharmacological distribution diagrams: A tool for de novo drug design

By Galvez J.   Garcia-Domenech R.   de Gregorio Alapont C.   de Julian-Ortiz J.V.   Popa L.  

Journal of Molecular Graphics, Vol. 14, Iss. 5, 1996-10 ,pp. : 272-276

Elsevier

Access to resources Recommend Favorite

A de Novo Design Probe of a Dopamine Receptor Ligand Based on a Theoretical Approach

By Baginski M.   Claudi F.   Giorgioni G.   Fontenla J.A.   Rosa E.   Cardellini M.  

Bioorganic Chemistry, Vol. 24, Iss. 4, 1996-12 ,pp. : 358-375

Academic Press

Access to resources Recommend Favorite

De novo design of a synthetic riboswitch that regulates transcription termination

By Wachsmuth Manja  

Nucleic Acids Research, Vol. 41, Iss. 4, 2013-02 ,pp. : 2541-2551

Oxford University Press

Access to resources Recommend Favorite